|
|||||
|
|
Optimal AraC‐Cytotoxicity to AML Cells Requires ERK5 Activity |
|
| Authors: | Ruifang Zheng George P. Studzinski |
| Affiliation: | Department of Pathology and Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark |
| Abstract: | |
| Keywords: | CYTARABINE (AraC) DNA DAMAGE MITOGEN ACTIVATED PROTEIN KINASES (MAPKs) ERK5 CELL CYCLE Bcl2 |